Aotai Biotech announced that the company previously reviewed and approved the use of overfunded capital to cancel and reduce the registered capital. The total repurchase capital was not less than 100 million yuan and not more than 200 million yuan, and the maximum repurchase price was 84.03 yuan/share. On August 11, 2026, the company completed the repurchase. A total of 3.626,500 shares were repurchased, accounting for 4.57% of the total share capital. The highest repurchase transaction price was 68.29 yuan/share, the lowest price was 41.88 yuan/share, and the total payment amount was 199 million yuan. The company will cancel the repurchased shares on August 13, 2026.

Aotai Biotech announced that the company previously reviewed and approved the use of overfunded capital to cancel and reduce the registered capital. The total repurchase capital was not less than 100 million yuan and not more than 200 million yuan, and the maximum repurchase price was 84.03 yuan/share. On August 11, 2026, the company completed the repurchase. A total of 3.626,500 shares were repurchased, accounting for 4.57% of the total share capital. The highest repurchase transaction price was 68.29 yuan/share, the lowest price was 41.88 yuan/share, and the total payment amount was 199 million yuan. The company will cancel the repurchased shares on August 13, 2026.